Fanal Pharmaceutical LLP
About Fanal Pharmaceutical LLP
Data last updated:
Fanal Pharmaceutical LLP is a limited liability partnership (LLP) based in Rajkot, Gujarat, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 February 2021 and has been in existence for over 5 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAV-8650. Its GSTIN is 24AAHFF6068N1ZZ (Gujarat).
The LLP has a total obligation of contribution of ₹5 Lakh. It is led by designated partners including Chetankumar Naranbhai Akbari and Keyur Bharatbhai Pansara.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 302 Patel Appartment Patel Nagar Main Road Near Mavdi Chowkdi 150 Feet Ring Road, Rajkot, Gujarat, India – 360004.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹3.58 Lakh. For the same year it recorded a net loss of ₹42.58 Lakh and EBITDA of -₹15.23 Lakh (EBITDA margin -425.4%).
As per MCA filings, the LLP has open charges of ₹2.13 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address302 Patel Appartment Patel Nagar Main Road Near Mavdi Chowkdi 150 Feet Ring Road, Rajkot, Gujarat, India – 360004
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Fanal Pharmaceutical LLP FY 2025 filings available
Fanal Pharmaceutical LLP reported revenue of ₹3.58 Lakh for FY 2023.
Financial Statement Summary of Fanal Pharmaceutical LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Income and Expenditure | |||
| Turnover | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Income | ₹3.58 Lakh | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• |
| Profit After Tax | -₹42.58 Lakh | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• |
| Assets and Liabilities | |||
| Partners' Contribution | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Fanal Pharmaceutical LLP
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| Net Profit Margin | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Fanal Pharmaceutical are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Fanal Pharmaceutical LLP
Fanal Pharmaceutical has 4 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chetankumar Naranbhai Akbari | Designated Partner | 11 Feb 2021 | 5 Years 8 Months | Current |
| Keyur Bharatbhai Pansara | Designated Partner | 11 Feb 2021 | 5 Years 8 Months | Current |
| Abhay Kishorbhai Pansara | Designated Partner | 22 Jan 2024 | 2 Years 8 Months | Current |
| Hiteshbhai Lalajibhai Dholariya | Designated Partner | 22 Jan 2024 | 2 Years 8 Months | Current |
Ownership and Shareholding of Fanal Pharmaceutical LLP
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Fanal Pharmaceutical LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jun 2025 | Hdfc Bank Limited | ₹2.13 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Fanal Pharmaceutical LLP
Employment history and EPFO contributions of people linked to Fanal Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Fanal Pharmaceutical LLP
Fanal Pharmaceutical LLP has 5 designated partner changes on record since 2021: 4 appointments and 1 cessation. The latest: Abhay Kishorbhai Pansara was appointed as Designated Partner on 22 Jan 2024.
Credit Ratings, Litigation & Regulatory Alerts for Fanal Pharmaceutical LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Fanal Pharmaceutical LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Fanal Pharmaceutical LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Fanal Pharmaceutical LLP
Fanal Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAHFF6068N1ZZ | Gujarat | Active | 01 Apr 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Fanal Pharmaceutical LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fanal Pharmaceutical LLP
Fanal Pharmaceutical is an active limited liability partnership based in Rajkot, Gujarat, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 February 2021 (5+ years old) and is registered under LLPIN AAV-8650.
Fanal Pharmaceutical reported revenue of ₹3.58 Lakh for FY 2023.
Fanal Pharmaceutical has 4 current designated partners:
- Chetankumar Naranbhai Akbari - Designated Partner
- Keyur Bharatbhai Pansara - Designated Partner
- Abhay Kishorbhai Pansara - Designated Partner
- Hiteshbhai Lalajibhai Dholariya - Designated Partner
Fanal Pharmaceutical reported a net loss of ₹42.58 Lakh and EBITDA of -₹15.23 Lakh (EBITDA margin -425.4%) for FY 2023, as per its filed financial statements.
The GSTIN of Fanal Pharmaceutical is 24AAHFF6068N1ZZ, registered in Gujarat.
The LLPIN (Limited Liability Partnership Identification Number) of Fanal Pharmaceutical is AAV-8650. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Fanal Pharmaceutical was incorporated on 11 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Abhay Kishorbhai Pansara was appointed as Designated Partner on 22 Jan 2024. Hiteshbhai Lalajibhai Dholariya was appointed as Designated Partner on 22 Jan 2024. Abhay Kishorbhai Pansara ceased to be Partner on 21 Jan 2024. Fanal Pharmaceutical has 5 designated partner changes on record in total.
Yes, Fanal Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Fanal Pharmaceutical is at 302 Patel Appartment Patel Nagar Main Road Near Mavdi Chowkdi 150 Feet Ring Road, Rajkot, Gujarat, India – 360004.